|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/50 | |||
| A61K 31/436 |
| (11) | Patento numeris | 2763663 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12766990.1 |
| Europos patento paraiškos padavimo data | 2012-10-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-08-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-12-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/069541 |
| Data | 2012-10-03 |
| (87) | Numeris | WO 2013/050419 |
| Data | 2013-04-11 |
| (30) | Numeris | Data | Šalis |
| 201161544026 P | 2011-10-06 | US |
| (72) |
DIEDERICH, Anke, CH
LIECHTI, Kurt, CH
KUEHL, Peter, CH
CHEUNG, Wing, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING 40-O-(2-HYDROXY)ETHYL-RAPAMYCIN |
| PHARMACEUTICAL COMPOSITIONS COMPRISING 40-O-(2-HYDROXY)ETHYL-RAPAMYCIN |